Skip to content
Corporate Investor early-stage venture Est. 2009

MiCoBioMed

Glucose monitoring and surface plasmon sensors, and devices

📍 Anseong, South Korea

About This Fund

MicoBiomed produces and sells glucose monitoring sensors and devices and glucose strips.It also produces sensors for Surface Plasmon Resonance (SPR) for planar surfaces or Localized Surface Plasmon Resonance (LSPR) for nanometer-sized metallic structures.

Investment Focus

Sectors
healthcare pharmaceuticals
Stages
early-stage venture
Check Size $1.9M average
Geography
Global

What They Look For

innovative solutions in medical and drug development that improve patient outcomes; e.g. SpecLips

Preparing to pitch MiCoBioMed?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →